Business Insider: Abbott Receives CE Mark for Next-Generation MitraClip™ Heart Valve Repair Device to Treat Mitral Regurgitation ABBOTT PARK, Ill., Sept. 21, 2020 /PRNewswire/ -- Abbott (NYSE: ABT) today announced it has received CE Mark for its fourth-generation MitraClip™ Transcatheter Mitral Valve Repair System, the leading ... Abbott Receives CE Mark for Next-Generation MitraClip™ Heart Valve Repair Device to Treat Mitral Regurgitation Abbott Laboratories has received an expanded indication for MitraClip.
The Abbott Park, IL-based company’s new indication addresses the secondary form of mitral regurgitation and significantly ... A new, retrospective study trying to tease out the benefits of MitraClip procedures according to the etiology of mitral regurgitation (MR) hints that, compared with conservative management, ... CHICAGO -- Emerging real-world data supported benefits of MitraClip therapy in patients with secondary mitral regurgitation (MR) who didn't fit the COAPT profile, the EXPAND study showed. MR was often ...
mitral clips, MUNICH, Germany (UPDATED)—In a setback to the field of transcatheter interventions for mitral valve disease, one of three hotly anticipated trials has failed to find a benefit of the MitraClip (Abbott ... Abbott Laboratories ABT recently announced FDA approval for its latest version of MitraClip heart valve repair device to treat mitral regurgitation (MR). With the approval for the fourth-generation ...
